MERIT MEDICAL SYSTEMS INC — Director's Dealing 2021

Mar 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2021-03-12

Reporting Person: Lampropoulos Justin J. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-12	Common Stock, No Par Value	M	5000	$12.06	Acquired	7343	Direct
2021-03-12	Common Stock, No Par Value	M	20000	$17.27	Acquired	27343	Direct
2021-03-12	Common Stock, No Par Value	S	25000	$59.58	Disposed	2343	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-12	Non-qualified stock options (right to buy)	$12.06	M	5000	Disposed	2021-10-04	Common Stock (5000)	Direct
2021-03-12	Non-qualified stock options (right to buy)	$17.27	M	20000	Disposed	2022-02-13	Common Stock (20000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-qualified stock options (right to buy)	$16.05	2023-01-28	Common Stock (20000)	20000	Direct
Non-qualified stock options (right to buy)	$28.20	2024-04-14	Common Stock (25000)	25000	Direct
Non-qualified stock options (right to buy)	$44.80	2025-03-02	Common Stock (20000)	20000	Direct
Non-qualified stock options (right to buy)	$55.73	2026-03-01	Common Stock (30000)	30000	Direct
Non-qualified stock options (right to buy)	$37.71	2027-02-26	Common Stock (16722)	16722	Direct

Footnotes

F1: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.945 to $59.50, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F2: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.

F3: Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.

F4: Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.

F5: Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018

F6: Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.

F7: Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.

F8: Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.